Tag: lurasidone
Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study
by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Dr. Nakamura is with the Department of Psychiatric Internal Medicine, Kosekai-Kusatsu Hospital in Hiroshima, Japan. Dr. Nagamine is with the Department of Psychiatric Internal Medicine, Sunlight Brain Research Center in Yamaguchi, Japan. Funding: No funding was provided for this study. Disclosures: The authors have no […]
Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR
by Philip D. Harvey, PhD; Cynthia O. Siu, PhD; and Antony D. Loebel, MD Dr. Harvey is with the University of Miami Miller School of Medicine in Miami, Florida, and the Research Service of the Bruce W. Carter VA Medical Center in Miami, Florida. Dr. Siu is with COS and Associates Ltd. in Central District, […]
Lurasidone: A New Treatment Option for Bipolar Depression— A Review
by Radhika Bawa, MD, and Jonathan R. Scarff, MD Dr. Bawa is with Lehman College, the City University of New York, Bronx, New York; and Dr. Scarff is with Veterans Affairs Outpatient Clinic, Spartanburg, South Carolina. Innov Clin Neurosci. 2015;12(1–2):21–23.
Letter to the Editor: A case of Paranoid Schizophrenia and severe antipsychotic-induced Parkinson’s Disorder treated with a combination of olanzapine and lurasidone
Oleg V. Tcheremissine, MD, and Danielle Englert, MD Dr. Tcheremissine is Research Director, Department of Psychiatry and Behavioral Sciences, Carolinas Healthcare System; Dr. Englert is Director of Deep Brain Stimulation Program Center for Parkinson’s Disease and Movement Disorders, Department of Neurology Carolinas Healthcare System, Charlotte, North Carolina. Innov Clin Neurosci. 2013;10(9–10):10–14
